| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Common Stock | Sale | -$355K | -4.8K | -5.44% | $74.05 | 83.4K | Feb 25, 2022 | Direct | F1, F2 |
| transaction | EXAS | Common Stock | Sale | -$51.1K | -680 | -0.82% | $75.15 | 82.7K | Feb 25, 2022 | Direct | F1, F3, F4 |
| holding | EXAS | Common Stock | 4.92K | Feb 25, 2022 | Held in 401(k) Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Restricted Stock Units | Award | $0 | +15.8K | $0.00 | 15.8K | Feb 25, 2022 | Common Stock | 15.8K | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in February 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.52 to $74.46, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.55 to $75.28, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F4 | In addition to the shares of Common Stock reported on this Form 4, which total 87,619 shares, Ms. Condella also holds, in the aggregate, an additional 86,779 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of common stock. |
| F6 | These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. |